Cargando…
Denosumab Chemotherapy for Recurrent Giant-Cell Tumor of Bone: A Case Report of Neoadjuvant Use Enabling Complete Surgical Resection
Giant-cell tumor of the bone (GCTB) is a rare neoplasm that affects young adults. The tumor is generally benign but sometimes can be locally aggressive. There are no standardized approaches to the treatment of GCTB. Recently, the RANKL inhibitor denosumab has shown activity in this tumor type. We pr...
Autores principales: | Agarwal, Amit, Larsen, Brandon T., Buadu, Lawrence D., Dunn, Jack, Crawford, Russell, Daniel, Jonathan, Bishop, Maria C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745896/ https://www.ncbi.nlm.nih.gov/pubmed/23984138 http://dx.doi.org/10.1155/2013/496351 |
Ejemplares similares
-
'Salvage Treatment' of Aggressive Giant Cell Tumor of Bones with Denosumab
por: Vaishya, Raju, et al.
Publicado: (2015) -
Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab
por: Chinder, Pramod Shekarappa, et al.
Publicado: (2019) -
Neoadjuvant denosumab for extensive giant cell tumor in os ischium —a case report
por: van der Heijden, Lizz, et al.
Publicado: (2015) -
Conversion in a Resectable Tumor after Denosumab Neoadjuvant in a Large Dorsal Giant Cells Tumor: A Case Report and a Literature Review
por: Sereno, María, et al.
Publicado: (2023) -
A case of primary pulmonary leiomyosarcoma completely resected after neoadjuvant chemotherapy
por: Tanaka, Kazuhisa, et al.
Publicado: (2019)